Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma
This study has been terminated.
(Early end of enrolment with regards to difficulty met to enrol patients despite previous protocol amendments.)
Sponsor:
Steba Biotech S.A.
Information provided by (Responsible Party):
Steba Biotech S.A.
ClinicalTrials.gov Identifier:
NCT00975039
First received: September 10, 2009
Last updated: July 4, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | September 2012 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |